| 2024-03-28 | +0.12 % |
|
| 2024-03-27 | +2.77 % |
|
| 2024-03-25 | -0.36 % |
|
| 2024-03-20 | -0.29 % |
|
| 2024-03-19 | +0.99 % |
- The article compares Insulet (NASDAQ:PODD) and Baxter International (NYSE:BAX) as large-cap medical companies based on risk, analyst recommendations, profitability, dividends, institutional ownership, earnings, and valuation, with Insulet being favored due to its stronger consensus rating and higher potential upside, leading Baxter International's stock to go up by 0.99% last night.
- The article discusses that Baxter International Inc. (BAX) stock went up by 0.99% last night, with analysts giving the stock a consensus rating of "Hold," attributing the increase partially to positive quarterly earnings results that surpassed expectations and a quarterly dividend being announced, indicating strong financial performance and shareholder value.
|
| 2024-03-13 | -0.49 % |
|
| 2024-03-05 | -0.21 % |
- The article discusses Ligand Pharmaceuticals participating in a fireside chat at the Barclays Annual Global Healthcare Conference, and it mentions partnerships with leading pharmaceutical companies including Baxter International. Baxter International's stock might have gone down due to various factors such as market conditions, company performance, industry news, or economic changes.
- The article discusses how shares of dialysis service providers rose due to less-than-expected effects of Novo Nordisk's diabetes drug, Ozempic, on chronic kidney disease patients, leading to investors shifting focus from GLP-1 drugs to cardiac events, which subsequently caused a decline in Baxter International's stock as they provide dialysis operations through their kidney care unit.
- The article discusses how shares of dialysis services providers saw an increase after data from Novo Nordisk's diabetes drug, Ozempic, showed less-than-expected benefits in chronic kidney disease patients, leading investors to believe that the focus of GLP-1 drugs was more on cardiac events rather than significant advancements in kidney disease treatment, causing Baxter International (BAX) stock to decline by -0.21%.
|
| 2024-03-04 | +3.63 % |
|
| 2024-03-01 | +0.22 % |
|
| 2024-02-29 | -1.54 % |
- The article discusses Elanco Animal Health Incorporated's response to Ancora Holdings Group, LLC's nomination of director candidates, highlighting Elanco's progress and shareholder rewards. Baxter International (BAX) stock went down possibly due to a combination of factors including broader market conditions, industry-specific news, or specific company-related developments.
- Summary: Kontoor Brands' strategic initiative, Project Jeanius, aims to enhance profitability through gross margin improvement and cost savings, despite facing challenges in the U.S. wholesale market and revenue decline. The company remains confident in its growth prospects for 2024 and is focused on driving efficiency and innovation to navigate the complex retail environment.
Reason for Baxter International (BAX) stock going down: The provided text contains information about Kontoor Brands (KTB) and its strategic initiatives, not Baxter International (BAX). Please provide more details specifically related to Baxter International (BAX) for further analysis on the stock decline.
- Baxter International (BAX) stock went down by -1.54% last night despite the company's participation in the Raymond James Annual Investors Conference, indicating that market sentiment may have been influenced by factors beyond the presentation, such as overall market conditions, industry trends, or individual investor decisions.
|
| 2024-02-27 | -0.36 % |
|
| 2024-02-26 | -1.29 % |
|
| 2024-02-23 | +1.29 % |
|
| 2024-02-22 | -0.52 % |
|
| 2024-02-16 | +0.68 % |
|
| 2024-02-15 | +3.28 % |
|
| 2024-02-13 | -1.71 % |
|
| 2024-02-08 | +2.74 % |
|
| 2024-02-06 | +3.06 % |
|
| 2024-02-05 | -1.15 % |
|
| 2024-02-02 | -0.54 % |
|
| 2024-02-01 | +1.29 % |
|
| 2024-01-26 | -0.51 % |
|
| 2024-01-22 | +0.31 % |
|
| 2024-01-05 | +1.37 % |
|
| 2024-01-04 | +1.31 % |
|
| 2023-12-29 | -0.36 % |
|
| 2023-12-14 | +3.51 % |
|
| 2023-12-13 | +2.56 % |
|
| 2023-12-12 | +0.74 % |
|
| 2023-12-08 | -1.04 % |
|
| 2023-11-30 | -0.88 % |
|
| 2023-11-28 | -0.22 % |
|
| 2023-11-21 | +0.22 % |
|
| 2023-11-15 | +2.79 % |
|
| 2023-11-14 | +1.9 % |
|
| 2023-11-10 | -0.03 % |
|
| 2023-11-09 | -3.58 % |
|
| 2023-11-06 | +1.56 % |
|
| 2023-11-02 | +4.45 % |
|
| 2023-11-01 | +1.11 % |
|
| 2023-10-18 | +0.69 % |
|
| 2023-10-17 | -0.44 % |
|
| 2023-10-16 | +0.44 % |
|
| 2023-10-12 | -3.15 % |
|
| 2023-10-11 | -12.27 % |
|
| 2023-10-06 | -1.08 % |
|
| 2023-10-03 | -1.53 % |
|
| 2023-10-02 | -1.03 % |
|
| 2023-09-29 | +0.53 % |
|